Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

GCT Selects CRO Starter Kit™ PSA Platform by Flex Databases

Published: Thursday, February 13, 2014
Last Updated: Thursday, February 13, 2014
Bookmark and Share
CRO Starter Kit™ provide increased efficiency and speed in running clinical research projects.

Flex Databases has announced that Global Clinical Trials, LLC (GCT) has selected Flex CRO Starter Kit™ as its business automation platform.

GCT is a regional Contract Research Organization (CRO), established in 2001 and headquartered in Princeton, NJ with full-service clinical operations in Russia and Eastern Europe.

"From the very foundation of the company GCT had a clear growth strategy", says Dr. Eugene Selivra, CEO of GCT. "We developed organically, step by step, basing our growth on the experience and knowledge of the management team and efficient business processes. But we always knew a time would come when we would need a software platform to help us handle the increased complexity, size and number of projects. We explored the market in search of a system that would become a core application, driving all of our day-to-day activities. The CRO Starter Kit™ platform became a perfect match for our needs. It has vital tools for a CRO today, such as budget management, eTMF, a Learning Management System, timesheets and more. But above all, CRO Starter Kit™ is a unique platform where ground level operational activities are seamlessly linked to project management, providing increased efficiency and speed in running clinical research projects."

"CRO Starter Kit™ is a platform which brings the company together, creating an environment where every action is interconnected with others", says Timur Galimov, Technical Director of Flex Databases. "Such a system becomes self-reinforcing and is much easier to adopt, because it touches a user from multiple angles. One of the big reasons why CTMS implementations fail is because they affect a limited number of users and become just another database, not connected to anything else and not affecting anything else. The experience and industry knowledge of GCT allowed them to avoid this pitfall by selecting Flex CRO Starter Kit™."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Scientists Test New Gene Therapy for Vision Loss from a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Multi-Gene Test Enables Some Breast Cancer Patients to Safely Avoid Chemotherapy
A major study is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack?
Heart attack patients live as long – or even longer – on one-quarter the suggested dose.
Antidepressants Plus Blood-Thinners Slow Down Brain Cancer
EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Electronic Reminders Keep TB Patients on Track With Medication In China
Giving electronic reminders to tuberculosis (TB) patients in China can reduce the amount of medication doses they miss by half, according to new research.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos